drugset / Trial / NCT00000595

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00000595

Treatment

Summary

To determine whether deferoxamine prevented the complications of transfusional iron overload.

Timeline

Start
1978-01
Primary completion
Completion
1994-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferoxamine Other / unclassified Subcutaneous